Scholay

学术搜索 · AI 审稿 · LaTeX 协作

María Poca

机构:Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Hospital de Sant Pau, Centro de Investigación Biomédica en Red, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ORCID:0000-0002-0235-1395

发表论文 102 篇 · 总被引 4254 次 · h-index 22

代表论文

  • Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized trial (2024 · Hepatology · 被引 17)
  • Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study (2025 · Hepatology · 被引 11)
  • Progressive systemic inflammation precedes decompensation in compensated cirrhosis (2024 · JHEP Reports · 被引 8)
  • Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction–associated Steatotic Liver Disease in Clinical Practice (2025 · Clinical Gastroenterology and Hepatology · 被引 6)
  • Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis (2025 · Nutrients · 被引 6)
  • Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics (2024 · Biomolecules · 被引 6)